News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK)'s Olympic Doping Facility to Research Personalised Medicines After Games



8/2/2012 8:08:54 AM

The anti-doping facility provided by GlaxoSmithKline (GSK) for the London 2012 Olympic and Paralympic Games will be turned into a research centre to develop personalised, targeted medicines after the sporting events finish. Funded and run by the UK’s Medical Research Council (MRC) and the Department of Health’s National Institute for Health Research (NIHR), the MRC-NIHR Phenome Centre will make use of GSK’s facilities in Harlow to analyse the metabolism of an individual or population set in an attempt to discover its link to how someone responds both to a disease and to treatment.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES